Resveratrol Protects Against Functional Impairment and Cardiac Structural Protein Degradation Induced by Secondhand Smoke Exposure

Canadian Journal of Cardiology

Volumn 29, Issue 10, 2013, Pages 1320-1328

  Arcand, Steven ^a   Sharma, Keshav ^a   Al Dissi, Ahmad N ^b   Cadete, Virgilio J J ^a   Sawicki, Grzegorz ^a,c   Weber, Lynn P ^b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; LACTATE DEHYDROGENASE; MYOSIN HEAVY CHAIN BETA; MYOSIN LIGHT CHAIN; MYOSIN VIIA; PYRUVATE DEHYDROGENASE; RESVERATROL; STRUCTURAL PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENZYME ACTIVITY; EXPERIMENTAL PIG; FUNCTIONAL DISEASE; GLUCOSE METABOLISM; HEART FUNCTION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART OUTPUT; HEART PROTECTION; HEART STROKE VOLUME; MALE; NONHUMAN; OXIDATIVE STRESS; PASSIVE SMOKING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEOMICS; SARCOMERE; TWO DIMENSIONAL ELECTROPHORESIS;

ANIMALS; ANTIOXIDANTS; DISEASE MODELS, ANIMAL; MALE; MYOCARDIUM; OXIDATIVE STRESS; PROTEINS; PROTEOLYSIS; PROTEOMICS; RECOVERY OF FUNCTION; STILBENES; SWINE; TOBACCO SMOKE POLLUTION; VASODILATOR AGENTS; VENTRICULAR DYSFUNCTION; VENTRICULAR FUNCTION;

EID: 84884594872     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2013.04.030     Document Type: Article

References (28)

1. Castardeli E., Duarte D.R., Minicucci M.F., et al. Tobacco smoke-induced left ventricular remodelling is not associated with metalloproteinase-2 or -9 activation. Eur J Heart Fail 2007, 9:1081-1085.
2. Rahman M.M., Laher I. Structural and functional alteration of blood vessels caused by cigarette smoking: an overview of molecular mechanisms. Curr Vasc Pharmacol 2007, 5:276-292.
3. Al-Dissi A.N., Weber L.P. Resveratrol preserves cardiac function, but does not prevent endothelial dysfunction or pulmonary inflammation after environmental tobacco smoke exposure. Food Chem Toxicol 2011, 49:1584-1591.
4. Gentner N.J., Weber L.P. Secondhand tobacco smoke, arterial stiffness, and altered circadian blood pressure patterns are associated with lung inflammation and oxidative stress in rats. Am J Physiol Heart Circ Physiol 2012, 302:H818-H825.
5. Sawicki G., Leon H., Sawicka J., et al. Degradation of myosin light chain in isolated rat hearts subjected to ischemia-reperfusion injury: a new intracellular target for matrix metalloproteinase-2. Circulation 2005, 112:544-552.
6. Polewicz D., Cadete V.J., Doroszko A., et al. Ischemia induced peroxynitrite dependent modifications of cardiomyocyte MLC1 increases its degradation by MMP-2 leading to contractile dysfunction. JCell Mol Med 2011, 15:1136-1147.
7. Chu L.M., Lassaletta A.D., Robich M.P., Sellke F.W. Resveratrol in the prevention and treatment of coronary artery disease. Curr Atheroscler Rep 2011, 13:439-446.
8. Kawada N., Seki S., Inoue M., Kuroki T. Effect of antioxidants, resveratrol, quercetin, and N-acetylcysteine, on the functions of cultured rat hepatic stellate cells and Kupffer cells. Hepatology 1998, 27:1265-1274.
9. Donnelly L.E., Newton R., Kennedy G.E., et al. Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms. Am J Physiol Lung Cell Mol Physiol 2004, 287:L774-L783.
10. ElAttar T.M., Virji A.S. Modulating effect of resveratrol and quercetin on oral cancer cell growth and proliferation. Anticancer Drugs 1999, 10:187-193.
11. Weber L.P., Al-Dissi A., Marit J.S., German T.N., Terletski S.D. Role of carbon monoxide in impaired endothelial function mediated by acute second-hand tobacco, incense, and candle smoke exposures. Environ Toxicol Pharmacol 2011, 31:453-459.
12. Doroszko A., Polewicz D., Sawicka J., Richardson J.S., Cheung P.Y., Sawicki G. Cardiac dysfunction in an animal model of neonatal asphyxia is associated with increased degradation of MLC1 by MMP-2. Basic Res Cardiol 2009, 104:669-679.
13. Liu S., Zhu Y. Acase study of exposure to ultrafine particles from secondhand tobacco smoke in an automobile. Indoor Air 2010, 20:412-423.
14. Gentner N.J., Weber L.P. Using blood pressure telemetry to assess acute changes in arterial stiffness in rats after nitric oxide synthase inhibition or environmental tobacco smoke exposure. Can J Physiol Pharmacol 2010, 88:918-928.
15. Gentner N.J., Weber L.P. Intranasal benzo[a]pyrene alters circadian blood pressure patterns and causes lung inflammation in rats. Arch Toxicol 2011, 85:337-346.
16. Taddei S., Caraccio N., Virdis A., et al. Low-grade systemic inflammation causes endothelial dysfunction in patients with Hashimoto's thyroiditis. JClin Endocrinol Metab 2006, 91:5076-5082.
17. Antoniades C., Tousoulis D., Vasiliadou C., et al. Combined effects of smoking and hypercholesterolemia on inflammatory process, thrombosis/fibrinolysis system, and forearm hyperemic response. Am J Cardiol 2004, 94:1181-1184.
18. May A., Wang T.J. Evaluating the role of biomarkers for cardiovascular risk prediction: focus on CRP, BNP and urinary microalbumin. Expert Rev Mol Diagn 2007, 7:793-804.
19. Gan W.Q., Man S.F., Sin D.D. The interactions between cigarette smoking and reduced lung function on systemic inflammation. Chest 2005, 127:558-564.
20. Fujii T., Hayashi S., Hogg J.C., et al. Interaction of alveolar macrophages and airway epithelial cells following exposure to particulate matter produces mediators that stimulate the bone marrow. Am J Respir Cell Mol Biol 2002, 27:34-41.
21. Denipote F., Ardisson L.P., Azevedo P.S., et al. Influence of taurine on cardiac remodeling induced by tobacco smoke exposure. Cell Physiol Biochem 2011, 27:291-298.
22. Anbarasi K., Sabitha K.E., Devi C.S. Lactate dehydrogenase isoenzyme patterns upon chronic exposure to cigarette smoke: protective effect of bacoside A. Environ Toxicol Pharmacol 2005, 20:345-350.
23. Belke D.D., Larsen T.S., Lopaschuk G.D., Severson D.L. Glucose and fatty acid metabolism in the isolated working mouse heart. Am J Physiol 1999, 277:R1210-R1217.
24. Dodd M.S., Ball D.R., Schroeder M.A., et al. Invivo alterations in cardiac metabolism and function in the spontaneously hypertensive rat heart. Cardiovasc Res 2012, 95:69-76.
25. Cadete V.J., Sawicka J., Jaswal J.S., et al. Ischemia/reperfusion-induced myosin light chain 1 phosphorylation increases its degradation by matrix metalloproteinase 2. FEBS J 2012, 279:2444-2454.
26. Demeule M., Brossard M., Page M., Gingras D., Beliveau R. Matrix metalloproteinase inhibition by green tea catechins. Biochim Biophys Acta 2000, 1478:51-60.
27. Gokulakrisnan A., Jayachandran Dare B., Thirunavukkarasu C. Attenuation of the cardiac inflammatory changes and lipid anomalies by (-)-epigallocatechin-gallate in cigarette smoke-exposed rats. Mol Cell Biochem 2011, 354:1-10.
28. Lu Y., Qin W., Shen T., et al. The antioxidant N-acetylcystein promotes atherosclerotic plaque stabilization through suppression of RAGE, MMPs and NF-κB in ApoE-deficient mice. JAtheroscler Thromb 2011, 18:998-1008.